GlobeStar Therapeutics Corporation GSTC
0.00 USD 0.00 (+0.00%)
At close·Nov 2, 2026, 4:00 PM EST
0.0001 52-week range 0.0001
- YTD
- 0.00%
- 1 year
- 0.00%
Altman Z-Score
-405.78 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.8×
P/S 0.0×
P/B -1.0×
P/FCF -7.2×
EV/EBITDA 291×
EV/Sales 0.0×
FCF Yield -13.8%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE 135.9%
ROIC 174.6%
ROA 0.0%
Revenue 0.0%
Operating Income -47.4%
EPS (diluted) 0.0%
Free Cash Flow 37.1%
Current Ratio 0.0×
Quick Ratio 0.0×
Debt / Equity -0.3×
Net Debt / EBITDA 57.5×
Interest Coverage -20.3×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2023-09-30